Regular Article
Expression of Human Amyloid Precursor Protein Ectodomains inPichia pastoris:Analysis of Culture Conditions, Purification, and Characterization

https://doi.org/10.1006/prep.1997.0748Get rights and content

Abstract

We have examined the use of the yeastPichia pastorisfor expression of the human amyloid precursor protein (APP). The ectodomains of the isoforms APP695, APP751, and APP770 were expressed in bothP. pastorisprotease-deficient strain SMD1163 and wild-type strain GS115, using the secretion vector pHIL-S1. Expression of recombinant APP in each of these strains produced intact recombinant protein, together with a small number of breakdown products. The levels of these breakdown products were not significantly altered by expression in the protease-deficient strain compared with wild-type GS115. The effects of induction time and medium composition on recombinant APP stability were also examined. After optimization of expression and culture conditions, baffled shaker flask cultures of clones selected for high expression routinely yielded 13–24 mg/liter recombinant protein following a two-step purification procedure. The recombinant isoforms possessed the heparin binding, metal binding, and Kunitz-type protease inhibitor properties of human brain-derived APP. These data indicate thatP. pastorisis an appropriate laboratory-scale expression system for production of sufficient quantities of recombinant APP for use in biological studies.

References (56)

  • W.E. Van Nostrand et al.

    Enhanced plasmin inhibition by a reactive center lysine mutant of the Kunitz-type protease inhibitor domain of the amyloid β-protein precursor

    J. Biol. Chem.

    (1995)
  • S.L. Wagner et al.

    High level expression, purification and characterization of the Kunitz-type protease inhibitor domain of protease nexin-2/amyloid β-protein precursor

    Biochem. Biophys. Res. Commun.

    (1992)
  • M. Romanos

    Advances in the use ofPichia pastoris

    Curr. Opin. Biotechnol.

    (1995)
  • R.B. Trimble et al.

    Structure of oligosaccharides onSaccharomycesPichia pastoris

    J. Biol. Chem.

    (1991)
  • C.A. Scorer et al.

    The intracellular production and secretion of HIV-1 envelope protein in the methylotrophic yeastPichia pastoris

    Gene

    (1993)
  • J.J. Clare et al.

    Production of mouse epidermal growth factor in yeast: High-level secretion usingPichia pastoris

    Gene

    (1991)
  • C.W. Despreaux et al.

    The dacA gene ofBacillus stearothermophilusdEscherichia coliPichia pastoris

    Gene

    (1993)
  • J. Sun et al.

    Production and characterisation of recombinant human proteinase inhibitor 6 expressed inPichia pastoris

    Biochim. Biophys. Acta

    (1995)
  • C. Hilbich et al.

    Amyloid-like properties of peptides flanking the epitope of amyloid precursor-specific monoclonal antibody 22C11

    J. Biol. Chem.

    (1993)
  • C. Holm et al.

    A rapid, efficient method for isolating DNA from yeast

    Gene

    (1986)
  • A.I. Bush et al.

    The amyloid beta-protein precursor and its mammalian homologues: Evidence for a zinc-modulated heparin-binding superfamily

    J. Biol. Chem.

    (1994)
  • M.A. Romanos et al.

    RecombinantBordetella pertussisPichia pastoris:

    Vaccine

    (1991)
  • W.E. Van Nostrand et al.

    Expression, purification, and characterization of the Kunitz-type proteinase inhibitor domain of the amyloid beta-protein precursor-like protein-2

    Biochim. Biophys. Acta.

    (1994)
  • R.G. Brankamp et al.

    Expression of a synthetic gene encoding the anticoagulant–antimetastatic protein ghilanten by the methylotropic yeastPichia pastoris

    Protein Expression Purif.

    (1995)
  • J. Kang et al.

    The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

    Nature

    (1987)
  • C.L. Masters et al.

    Amyloid plaque core protein in Alzheimer disease and Down syndrome

    Proc. Natl. Acad. Sci. USA

    (1985)
  • G. Evin et al.

    Alzheimer's disease amyloid precursor protein (AβPP): Proteolytic processing, secretases and βA4 amyloid production

    Int. J. Exp. Clin. Invest.

    (1994)
  • Cited by (49)

    • Evaluation of the effects of treatment with sAPPα on functional and histological outcome following controlled cortical impact injury in mice

      2012, Neuroscience Letters
      Citation Excerpt :

      This time point has been previously used to examine the effects of sAPPα treatment on functional and histological outcome following a diffuse injury in rats [6,31], with ICV administration of sAPPα shown to result in a homogenous distribution of sAPPα throughout the rat brain and at a higher concentration compared to shams [27]. The sAPPα was produced as previously described, expressed as a secreted protein in the methylotrophic yeast, Pichia pastoris [15]. 150 μL of 25 μM sAPPα was then combined with 75 μL of aCSF to produce the final solution used to treat the mice.

    • α-secretase-derived fragment of cellular prion, N1, protects against monomeric and oligomeric amyloid β(Aβ)-associated cell death

      2012, Journal of Biological Chemistry
      Citation Excerpt :

      Protein expression was induced during 48 h in BMMY (1% yeast extract, 2% peptone, 1.34% yeast nitrogen base without amino acids (Sigma), 4 × 10−5% biotin (Sigma), 2% methanol (Merck)). Purification was carried out on ice using a modification of the method of Henry et al. (30). Yeast cultures (0.5–2 liters) were centrifuged at 16,000 × g for 10 min at 4 °C, and supernatants were filtered (0.45 μm; Whatman).

    View all citing articles on Scopus

    J. E. Coligan, Ed.

    1

    To whom correspondence should be addressed. Fax: +61-3-9344 4004. E-mail: [email protected].

    View full text